热门资讯> 正文
Day One Biopharmaceuticals Files Shelf for Share Sale by Stockholders
2024-08-29 05:50
05:50 PM EDT, 08/28/2024 (MT Newswires) -- Day One Biopharmaceuticals (DAWN) filed a shelf registration statement with the US Securities and Exchange Commission covering the potential sale of up to about 12.1 million shares by some shareholders from time to time.
The statement covers about 10.6 million shares held by certain selling stockholders and around 1.5 million shares issuable upon exercise of some pre-funded warrants, the filing showed.
Day One shares were down about 3.4% in after-hours activity.
Price: 13.55, Change: -0.47, Percent Change: -3.35
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
